Diabetic foot clinical results: our key figures

DEXERYL Emollient Cream

Statistically significant effectiveness proven in clinical studies on over 1000 patients. These studies were conducted against a placebo or comparator, providing the highest level of scientific evidence

Discover the Emollient Cream

DEXERYL significantly reduces dryness of the foot in diabetic patients

Regular application of Dexeryl Emollient Cream, twice a day, on the feet, for 28 days, allows a significant reduction of 41% of the skin dryness of the foot in diabetic patients¹.

Xerosis Assessment Scale (XAS) score on day 1 and day 28 after treatment with DEXERYL Emollient Cream. Graphic created by Pierre Fabre.

METHODOLOGY

Aim

To evaluate the efficacy of an emollient cream (DEXERYL) on xerosis of the feet in diabetic patients.

Study

Prospective, randomised, multicentre, double-blind clinical trial. Contralateral vehicle-controlled (placebo) study.

Population

57 diabetic patients.

Dosage

2 applications daily.

Duration

28 days

Primary evaluation criteria

Assess the severity of xerosis (XAS score) after 28 days of treatment with Dexeryl compared to vehicle-treated feet

Secondary evaluation criteria

Evolution of the XAS score at D14 and the global skin score. Number of feet with cracks, deep cracks, hyperkeratosis, threatening hyperkeratosis and xerosis at D14 and D28. Hydration index measured by corneometry and xerosis by image analysis on D-squame test at D14 and D28. Skin relief at D14 and D28. Subjects' views on treatment

Tolerance

DEXERYL is safe and well tolerated.

Caring for the feet of diabetics

Type 1 and type 2 diabetes can both cause skin symptoms and conditions. The feet of diabetics are not spared¹. What happens to the skin of diabetics? And, in particular, the feet? What are the causes? And the complications? How do you take care of your feet when you have diabetes?

Learn more about dry feet in diabetic patients